BLLXF - Sire Bioscience Inc.

Sire Bioscience Inc.

213 Sterling Road
Suite 206
Toronto, ON M6R 2B2
Canada
416 262 0871
http://www.sirebioscience.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Jeffrey Zanini	Strategic Advisor	N/A	N/A	1969
Mr. Brian Polla	CEO, COO, Founder & Director	N/A	N/A	N/A
Mr. Domenic Crudo	CFO & Corp. Sec.	N/A	N/A	1965
Mr. Adrian Burke	Director of Marketing & Director	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Sire Bioscience Inc. invests in, cultivates, produces, and sells various hemp and cannabis products in Canada. It offers cannabidiol (CBD) based wellness products, oils, and edibles, as well as animal and pet related CBD products under the yumz, MEDIflower, BIONIC, PURPLEK, INFUSIONS, CANNA BANANA, cancan, FUR BABY, CBDTECH, and LEAFBELIEF. The company is headquartered in Toronto, Canada.

Corporate Governance

Sire Bioscience Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.